CA
NZ
UK
AU
IND
US
Host Hotels & Resorts, Inc. and Host Hotels & Resorts, L.P. filed a combined quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the quarterly period ended September 30, 2026.
FB Financial Corp General Counsel and Corporate Secretary Beth W. Sims filed a Form 4 on November 6, 2026, disclosing a gift of 500 shares of common stock and a trust transfer of 22,506 shares, both transacted on November 4, 2026.
Christopher W. Silcock, an officer of Hilton Worldwide Holdings Inc., filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 15,638 common shares acquired through a stock option exercise on the same date.
Koppers Holdings Inc. filed its Form 10-Q with the SEC on November 6, 2026, covering the quarterly period ended September 30, 2026, reporting third-quarter net income of $14.7 million against a nine-month net loss of $125.7 million driven by impairment and restructuring charges of …
First Mid Bancshares, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter net income of $33.3 million and total assets of $9.39 billion.
McDonald's Corporation filed its Form 10-Q with the Securities and Exchange Commission on November 6, 2026, covering the quarterly period ended September 30, 2026, reporting third-quarter and nine-month financial results for the period.
Dollar General Corp EVP and Chief Merchandising Officer Bryan D. Wheeler filed a Form 4 on November 6, 2026, disclosing a November 4, 2026 transaction in which 1,647 shares of common stock were surrendered to the company to cover taxes associated with the vesting …
Dollar General Corp EVP of Store Operations Tracey N. Herrmann filed a Form 4 on November 6, 2026, disclosing a tax-withholding transaction on November 4, 2026, in which 1,647 shares of common stock were surrendered to the company in connection with the vesting of …
Perspective Therapeutics, Inc. filed a Form 8-K on November 6, 2026, disclosing that it issued a press release and posted a poster presentation announcing updated interim results from its Phase 1/2a clinical trial of [212Pb]lapemelanotide zapixetar (VMT01) for unresectable or metastatic melanoma.
Camden Property Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026, reporting third-quarter net income of $906.8 million driven largely by a $973.5 million gain on the sale of operating …
Please wait processing your request...